Hims & Hers Q2 Losses Wider Than Expected Despite 38% Revenue Surge

Key Facts

1Hims & Hers reported Q2 revenue of $753.21 million, a 38% increase year-over-year.

2The company recorded a loss of $0.37 per share, significantly wider than analyst expectations due to declining margins and rising expenses.

3The company faces an FTC lawsuit alleging the sharing of sensitive health data and deceptive billing practices.

Amid intensifying regulatory scrutiny in the digital healthcare sector, Hims & Hers reported mixed results for the second quarter of 2026. While the company achieved robust revenue growth of 38% year-over-year to reach $753.21 million, it recorded a loss of $0.37 per share, significantly wider than analyst expectations. This downturn was primarily driven by declining gross margins and rising operating expenses, which deepened losses despite a growing subscriber base.

These financial headwinds coincide with serious legal challenges, as the company faces an FTC lawsuit alleging the sharing of sensitive health data and deceptive billing practices. According to reports, these developments have triggered further securities-law investigations by legal firms. In a related context, Deutsche Bank analysts adjusted their price target to $26 while maintaining a Hold rating, reflecting caution toward future profitability as gross margins compressed to 64% per market data.

With real-time price data for Hims & Hers currently unavailable, investors are monitoring how these legal pressures will impact the stock's performance in upcoming sessions. On the macroeconomic front, economic calendar data from August 5 showed the US ISM Non-Manufacturing Prices index rising to 70.3, indicating persistent inflationary pressure in the services sector. Traders will watch for any new legal updates that could impact the company's updated full-year revenue guidance of $3.1 billion to $3.3 billion.

Sources:

Financial Modeling Prep